ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.01
-1.49%
US Tech 100
18,939.60
-3.72%
S&P 500
5,614.56
-2.70%
US Dollar vs CAD
1.44376
0.46%
Bitcoin
79,258.87
-1.65%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Shield Therapeutics Plc (STX) Share Price

Shield Therapeutics Plc

Shield Therapeutics Plc (STX)

Strike Energy Limited
Starrex International Ltd
Seagate Technology Holdings PLC
3.30
-0.15
(-4.35%)
Closed March 10 11:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.30
Bid
3.20
Ask
3.40
Volume
2,367,895
3.30 Day's Range 3.45
1.075 52 Week Range 5.80
Market Cap
34.376M
Previous Close
3.45
Open
3.45
Last Trade
33
@
3.4
(O)
Last Trade Time
Financial Volume
80,508p
VWAP
3.40
Average Volume (3m)
2,545,928
Shares Outstanding
1,041,690,484
Dividend Yield
-
PE Ratio
-1.03
Earnings Per Share (EPS)
-0.03
Revenue
13.09M
Net Profit
-33.29M

About Shield Therapeutics Plc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.shieldtherapeutics.com
Headquarters
Newcastle Upon Tyne, Gbr
Founded
-
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 3.45p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.075p to 5.80p.

Shield Therapeutics currently has 1,041,690,484 shares outstanding. The market capitalization of Shield Therapeutics is £35.94 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -1.03.

Ask ADVFN Intelligence (AI)

STX Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.051.538461538463.253.53.2513942833.40050422DE
40.31034.1328958533.59687206DE
120.55202.754.12.2525459283.10716322DE
26-1.8-35.29411764715.15.12.2527806273.35986541DE
520.77530.69306930692.5255.81.07536255842.9076205DE
156-15.2-82.162162162218.521.251.07527179345.10721722DE
260-123.2-97.3913043478126.51501.075192716212.11469068DE

STX - Frequently Asked Questions (FAQ)

What is the current Shield Therapeutics share price?
The current share price of Shield Therapeutics is 3.30p
How many Shield Therapeutics shares are in issue?
Shield Therapeutics has 1,041,690,484 shares in issue
What is the market cap of Shield Therapeutics?
The market capitalisation of Shield Therapeutics is GBP 35.94M
What is the 1 year trading range for Shield Therapeutics share price?
Shield Therapeutics has traded in the range of 1.075p to 5.80p during the past year
What is the PE ratio of Shield Therapeutics?
The price to earnings ratio of Shield Therapeutics is -1.03
What is the cash to sales ratio of Shield Therapeutics?
The cash to sales ratio of Shield Therapeutics is 2.62
What is the reporting currency for Shield Therapeutics?
Shield Therapeutics reports financial results in USD
What is the latest annual turnover for Shield Therapeutics?
The latest annual turnover of Shield Therapeutics is USD 13.09M
What is the latest annual profit for Shield Therapeutics?
The latest annual profit of Shield Therapeutics is USD -33.29M
What is the registered address of Shield Therapeutics?
The registered address for Shield Therapeutics is NORTHERN DESIGN CENTRE, BALTIC BUSINESS QUARTER, GATESHEAD QUAYS, NEWCASTLE UPON TYNE, NE8 3DF
What is the Shield Therapeutics website address?
The website address for Shield Therapeutics is www.shieldtherapeutics.com
Which industry sector does Shield Therapeutics operate in?
Shield Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ROQRoquefort Therapeutics Plc
2.30p
(48.39%)
33.61M
GCMGcm Resources Plc
1.825p
(30.36%)
8.01M
CORACora Gold Limited
3.95p
(27.42%)
2.15M
EMHEuropean Metals Holdings Limited
8.25p
(26.92%)
1.07M
ATMAndrada Mining Limited
3.375p
(21.62%)
121.54M
CAPDCapital Limited
60.60p
(-21.30%)
3.66M
CKNClarkson Plc
3,510.00p
(-20.41%)
465.72k
BIOMBiome Technologies Plc
1.00p
(-20.00%)
703.46k
ZOOZoo Digital Group Plc
10.875p
(-17.92%)
13.45M
CTAICatenai Plc
0.21p
(-17.65%)
13.8M
VELAVela Technologies Plc
0.0028p
(0.00%)
1.35B
PREMPremier African Minerals Limited
0.01225p
(-5.04%)
461.14M
ORCPOracle Power Plc
0.0165p
(0.00%)
382.37M
LLOYLloyds Banking Group Plc
69.38p
(-2.17%)
355.11M
SYMESupply@me Capital Plc
0.0037p
(0.00%)
217.78M

Discussion

View Full Feed
Pro_v12001 Pro_v12001 5 minutes ago
This is new. Instead of just giving material to Polariton, we are now actively engaging with the end-user.

We are transitioning from being a material supplier to collaborating on market development through end-user engagement and technical cooperation.
LWLG
glenn1919 glenn1919 5 minutes ago
...........................................thx...........................................out
TNON
learningcurve2020 learningcurve2020 5 minutes ago
You really crack me up trying to pass off this crazy narrative here that these foolish immunologist don’t keep up with the times. 🤣🤣🤣
NWBO
northam43 northam43 5 minutes ago
SPX Weekly Chart

https://investorshub.advfn.com/uimage/uploads/2025/3/10/wbowqWeekly_Chart.png
JJones65 JJones65 5 minutes ago
They are running $CUTR when soon it will be untradable, not even on the OTC from what I'm reading. Anyone read the news?
CUTR
resx18 resx18 6 minutes ago
Great day $CBDW
CBDW
pos_stock_hoarder pos_stock_hoarder 6 minutes ago
Sing along....

Nothin' from nothin' leaves nothin'
SHMN
janice shell janice shell 6 minutes ago
Srsly?? If so, he's even crazier than I thought.
johnydollar johnydollar 6 minutes ago
We were to sell quickly to avoid kramers takeover........


Kramers failed.........

Then $DBMM was told to RIP due to revocation........

But they keep resurrecting $DBMM.........

Oh well.........

😆 🤣 &#x
DBMM
tw0122 tw0122 6 minutes ago
5.34 + 25% a little more life 
LFMD
100lbStriper 100lbStriper 7 minutes ago
In case there are any concerns or misunderstandings regarding today's BOC case conference, I'd like to explain what has changed and what may change going forward....NOTHING!

There was no delay, change, or cancellation of the trial date, and neither party will have an issue with Scar
NLST
Moneysign5 Moneysign5 8 minutes ago
I highly doubt he will let this go back to EM
TPTW
333randy 333randy 8 minutes ago
i keep waiting with money
ALST
tw0122 tw0122 8 minutes ago
MYO 5.35 + 28%
MYO
100lbStriper 100lbStriper 8 minutes ago
Stokd $NLST Minutes from today's conference are out...very interesting. Apparently, the reason for the hearing/issue is Scarsi's prior relationship with Samsung's O'melveny attorneys — Yagura & Petrocelli — haven't heard of Messers but must be same issue.

This:
"By not lat
NLST
ergo sum ergo sum 8 minutes ago
Musk is blaming Ukraine
The Dark KnaDDir The Dark KnaDDir 8 minutes ago
Not a single member of the board of directors or senior management did anything to stop Pourhassan. They let him speak outrageous lies unchecked. They did not fire him; he resigned. As he was not officially fired, he did get his golden parachute. All those Proactives went on and on full of lies unti
CYDY
dennisdave dennisdave 9 minutes ago
All of Linda Powerless' strategies are working great.


you dont understand she's setting a trap for shorts Mike 🤣
NWBO
Hoskuld Hoskuld 9 minutes ago
This is probably not the right forum, but the deficit problem is solvable. We have to attack it the same way we did rebuilding Europe with the Marshal Plan post-WW2: we tax ourselves at a high rate and pay it down. The annual deficit is something that ballooned from 350b at the end of the Obama ad
AVXL
$2.00 or no deal $2.00 or no deal 10 minutes ago
Dow Jones: -2.08% Loser!
S&P 500: -2.69% Loser!
Nasdaq: -4.00% Loser!
ELTP: +.73% Winner!
ELTP
wingnutt01 wingnutt01 10 minutes ago
I'm knowledgeable of at least one Large stock investor who sold a large portion of his F&F
to cover some speculative investments that were going in the wrong direction. He hated to
sell with just a small gain. But feels comfortable that getting back in will be at worst a wash.
Spuds McKenz66 Spuds McKenz66 10 minutes ago
ya knew it , i can always pull a rabbit out of a hat BOF
BOF
PennyMillions852 PennyMillions852 10 minutes ago
Agreed…at this point I don’t even think the name change will happen or we will ever see audited fins…as I said…today this broke ALL SUPPORT!!
IGPK
tdbowieknife tdbowieknife 11 minutes ago
No... Read it again.

This is the one before Primior where GRLT shows ZERO assets...

https://www.otcmarkets.com/otcapi/company/financial-report/410213/content



..


.


Buyer Beware
Pump a
GRLT

Your Recent History

LSE
STX
Shield Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads